RDIF and Panacea Biotec partner to produce 100 mn doses of Sputnik V vaccine in India annually
The Russian Direct Investment Fund (RDIF) and Panacea Biotec announce cooperation to produce 100 million doses per year of…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
COVID-19 vaccines
Prioritising who receives COVID-19 vaccine first saves lives: Research
They found that deaths, years of life lost and infections were between 17 and 44 per cent lower when vaccinations targeted…
COVID-19 vaccines from Pfizer, Moderna very effective after first shot: US real-world study
The risk of infection fell 90 per cent by two weeks after the second shot, the study of nearly 4,000 US healthcare personnel and…
We have supplied more vaccines globally than have vaccinated our own people: India to UN
India was one of the initiators of the 'Political Declaration on Equitable Global Access to COVID-19 Vaccines' that garnered the…
SCHOTT reaches COVID-19 milestone: vials for one bn vaccine doses delivered
Global specialty glass leader and pharmaceutical packaging supplier SCHOTT has delivered vials to provide more than one billion…
RDIF, Virchow Biotech sign agreement to produce 200 million doses of Sputnik V vaccine
The technology transfer is expected to be completed in the second quarter of 2021 followed by full-scale commercial production of…
New data boosts AstraZeneca COVID-19 vaccine in US
The trials in the US, Chile and Peru showed the vaccine was 79 per cent effective at preventing symptomatic COVID-19
South Africa sells COVID-19 vaccines procured from AstraZeneca to other AU member states
The country had paused AstraZeneca vaccinations last month because of a small trial showing the shot offered minimal protection…
L M College of Pharmacy organises international e-Conference on Biologics in Healthcare
A plethora of speakers from biotech companies and universities in the US and India shared their expert knowledge and experience on…
RDIF, Stelis Biopharma join hands for 200 mn doses of Sputnik V vaccine
The parties intend to commence supplies from the Q3 of 2021